Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Termination of Bilateral Investment Treaties Has Not Negatively Affected Countries’ Foreign Direct Investment Inflows April 16, 2018
Fact Sheet: NAFTA’s Legacy: Expanding Corporate Power to Attack Public Interest Laws October 12, 2018